Sign in to continue:

Thursday, April 9th, 2026

Author: Minichart

HBM Holdings Receives NMPA Approval for Investigational New Drug HBM7575 for Atopic Dermatitis 1

HBM Holdings Limited: IND Approval for HBM7575/SKB575 for At...